Many healthcare organizations are taking a fresh look at their data, hoping to exploit it better for both clinical outcomes and operations. To the experts at Clearsense, the problems are not so much the…
Continue Reading
Generic drugs giant Dr. Reddy’s is acquiring the U.S portfolio of Mayne Pharma in a deal that includes a birth control pill Mayne has described as its most significant product opportunity.
Under deal terms announced…
The healthcare system assists in the cure of diseases, the extension of lives, and the improvement of the well-being of communities. With the use of secure health information technology, healthcare will benefit…
Continue Reading
Amid swirling accusations that Medicare Advantage Organizations (MAOs) are overbilling the U.S. government and calls for better oversight, the Centers for Medicare & Medicaid Services announced in early February that it would investigate overbilling by those plans. They expect to recoup 4.7 billion dollars through this program.
This article focuses on the relatively young technologies that enable CMS to uncover overbillings, whether they be errors or fraud. The article is based on an interview with Kel Pults, chief clinical officer and vice president of MediQuant. A future article will explain how Medicare Advantage plans are trying to improving data collection and reporting,…
Healthcare analytics company MDI Health scored $20 million in Series A funding, bringing the company’s total funding to $26 million.Intel Capital led the round, with participation from Maverick Ventures Israel, alongside existing investors Fresh.Fund, Arc Impact, Hanaco Ventures, Jumpspeed Ventures, former Optum senior vice president Richard Montwill, Welltech Ventures and Basad Ventures.
Yoni Greifman, Intel Capital’s investment director, will join MDI’s board of directors.
WHAT IT DOES
Israel-based MDI offers an AI-enabled tool that provides medication risk analysis based on a patient’s medical records with the aim of preventing adverse drug reactions.
The funds will help the company scale its U.S. and Israeli research and…
